Public health impact of human papillomavirus vaccination on prevention of cervical cancer in France
✍ Scribed by Abdelkader El Hasnaoui; Nadia Demarteau; Denis Granados; Baudouin Standaert; Bruno Detournay
- Publisher
- SP Birkhäuser Verlag Basel
- Year
- 2011
- Tongue
- English
- Weight
- 299 KB
- Volume
- 57
- Category
- Article
- ISSN
- 1661-8556
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Vaccines based on human papillomavirus (HPV) 16 and 18 virus‐like particles have the potential to prevent ∼70% of cervical cancers. In Australia, public vaccination against HPV commenced in April 2007, and includes routine vaccination of females aged 12–13 years, and a 2‐year school and
## Abstract Cervical cancer is a major cause of death, and the second most frequent cancer in women worldwide. Many studies have indicated a causal relation between genital human papillomavirus (HPV) infections and cervical cancer. High‐risk HPV genotypes have been detected in almost 100% of all ce
## Abstract The aim of this study was to determine the proportion of invasive cervical cancers attributable to human papillomavirus (HPV) types 16 and 18 in a contemporary, cytologically well‐screened UK population. This was achieved in a retrospective observational analysis by HPV typing 453 archi
## Abstract This study assessed the cost‐effectiveness of a new, rapid human papillomavirus (HPV)‐DNA screening test for cervical cancer prevention in the high‐risk region of Shanxi, China. Using micro‐costing methods, we estimated the resources needed to implement preventive strategies using cervi